Abstract. Paeoniflorin (PF) is an active ingredient of Radix Paeoniae, which is known to exert neuroprotective effects. However, the mechanims behind the neuroprotective effects of PF are not yet fully understood. The apoptosis of neurons plays an important role in the cerebral ischemia-induced cascade response. This study aimed to investigate neuroprotective effects of PF against glutamate-induced PC12 cellular cytotoxicity and to determine whether these effects are mediated via the inhibition of apoptosis in vitro and the activity of mitochondrial apoptosis-associated proteins in PC12 cells. Exposure of the PC12 cells to glutamate induced cell morphological changes, significantly decreased cell viability and induced apoptosis, with similar results being observed from the Hoechst 33342 staining and Annexin V/PI staining experiments. Glutamate also increased the lactate dehydrogenase release by the PC12 cells. However, treatment with PF prevented these effects. Furthermore, PF inhibited Bax and Bad expression and increased Bcl-2 and Bcl-xL expression; it also decreased the levels of downstream protein (caspase-3 and caspase-9). Collectively, our results indicate that PF protects PC12 cells against glutamateinduced neurotoxicity possibly through the inhibition of the expression of mitochondrial apoptosis-associated proteins.
Introduction
Stroke is the third cause of mortality worldwide and is clinically characterized by a clear three-high (high incidence, high morbidity and high mortality) phenomenon (1, 2) . Ischemic stroke, which affects approximately 80% patients with stroke, is currently a mainly leading cause of disability and mortality in the aged population, due to limited medication and therapy (3) . Nowadays, the only FDA-approved treatment for ischemic stroke is plasminogen activator, which is administered within 4.5 h of stroke onset (4) . Therefore, novel therapeutic strategies are urgently required.
Recently, several hypotheses have been put forward to explain the pathophysiological processes of stroke. Increasing evidence indicates that neuronal cell death is a main cellular event in the pathogenesis of ischemic brain injury, which is often in the form of apoptosis (5) . Apoptosis is characterized by cell shrinkage, chromatin condensation, and the formation of cytoplasmic blebs and apoptotic bodies, which lead to changes in cell permeability and cell membrance damage (6) . 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, as well as lactate dehydrogenase (LDH) assay are usually employed to evaluate cell viability. Succinate dehydrogenase in the mitochondria of living cells can revert exogenous MTT into formazan; however, it cannot do so in dead cells. LDH is a soluble cytosolic enzyme present in most eukaryotic cells and can be released into the culture medium upon cell death due to plasma membrane damage (7) . Thus, MTT and LDH assays are regarded as the a valuable enzyme parameters in apoptosis.
The mitochondrial pathway is a central pathway leading to apoptosis in cerebral ischemia (8, 9) . A number of genes and proteins can influence or instigate the progression of apoptosis along the mitochondrial pathway (10) . The most important genes associated with apoptosis are proteins of the Bcl family and caspases (11, 12) . Bcl-2/Bax family members are key regulatory factors in the mitochondrial apoptotic pathway (13, 14) . They are divided into two groups, anti-apoptotic (Bcl-2, Bcl-xL) and pro-apoptotic (Bax, Bad) proteins. Upon stimulation with pro-apoptotic factors, Bax translocates from the cytoplasm to inthe mitochondrial membrane, which alters the permeability of the mitochondrial membrane and promotes the release of cytochrome c (Cyt c) from the mitochondria into the cytoplasm (11) . It has been proven that the activity of the Bcl-2 protein may be regulated through caspase cleavage under various circumstances. The apoptotic cascade is subsequently initiated, eventually leading to apoptosis (15) .
Mitochondrial dysfunction leads to characteristic morphological changes in neurons and results in abnormal upstream and downstream protein expression in the mitochondrial pathway (16) .
In order to combat neuronal cell death, nowadays, researchers are focusing on herbal extracts or their compounds due to their novel structures and few side-effects. Paeoniflorin (PF) (Fig. 1) , a monoterpene glycoside, is a natural compound and the main active ingredient of Radix Paeoniae (dried root of Paeonia lactiflora Pall.). It has been reported that PF exerts neuroprotective effects in in vivo models of cerebral ischemia (17) (18) (19) (20) (21) (22) and in in vitro models of cell injury induced by H 2 O 2 (23), 1-methyl-4-phenylpyridinium (MPP + ) (24) , glutamate (25) , Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (26) and lipopolysaccharide (27) . The effects of PF have been attributed to the involvement of multiple modulatory pathways, such as anti-oxidative stress and anti-inflammatory. Moreover, our recent study suggested that PF exerted stable and potent neuroprotective effects against cerebral ischemic injury and protected against N-methyl-D-aspartate (NMDA)-induced cell apoptosis and neuronal loss (22) . In a previous study of ours, we also found that PF was one of the compounds found in the brain tissue and cerebrospinal fluid of rats administerd PF after suffering cerebral ischemia injury (28) . Thus, as a continuation, the aim of this study was to further investigate the neuroprotective effects of PF against glutamate-induced PC12 cellular cytotoxicity and to elucidate whether the mitochondrial apoptosis-associated pathway is involved in these neuroprotective effects. Furthermoe, we investigated whether the cellular permeability of PF is associated with its protective effects.
Materials and methods
Reagents. PF (>98% purity) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Dimethyl sulfoxide (DMSO), glutamate, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Hoechst 33342 were all purchased from Sigma-Aldrich (St. Louis, MO, USA). Trypsin, RPMI-1640 medium, fetal bovine serum (FBS) and penicillin-streptomycin were all purchased from Hyclone (Logan, UT, USA). The LDH assay kit was from Nanjing Jiancheng Biochemical Reagent Co., Ltd. (Nanjing, China). The Annexin V/propidium iodide (PI) apoptosis assay kit was obtained from Roche Diagnostics (Indianapolis, IN, USA). Antibodies to caspase-3 (#9665), caspase-9 (#9508), Bcl-xL (#2764), Bcl-2 (#3498), p-21 (#2947), p-53 (#2524) and cleaved PARP (#9545) were all purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Antibodies to p-Bad and Bax were both obtained from Sangon Biological Engineering Co., Ltd. (Shanghai, China). The secondary antibodies were from Xiamen Lulong Biotech Development Co., Ltd. (Xiamen, China). Polyvinylidene fluoride membranes were from Merck KGaA (Darmstadt, Germany). All other reagents were from the Beyotime Institute of Biotechnology (Nanjing, China) unless otherwise stated.
Cell culture and treatment. PC12 cells (North Carolina Chuanglian Biotechnology Research Institute, Beijing, China) were maintained in RPMI-1640 medium supplemented with 10% FBS and 1% penicillin-streptomycin mixed solution at 37̊C in a 5% CO 2 incubator. After seeding onto 96-, 24-or 6-well plates for 24 h, the cells were cultured in medium without serum and incubated in the presence or absence of various concentrations of PF for 24 h followed by exposure to glutamate for 24 h. The control cells were not treated with PF or glutamate as the vehicle control. The glutamate-exposed cells were treated with glutamate for 24 h alone.
Determination of cell viability. Cell viability was measured by MTT assay, as well as by LDH assay. Briefly, for the MTT assay, following treatment, 10 µl MTT solution (5 mg/ml) were added to each well for an additional 4 h of incubation. The MTT reagent was then replaced with DMSO (100 µl/well) carefully to dissolve the formazan crystals. The absorbance at 570 nm was measured using a microplate reader (Infinite M200 Pro; Tecan, Männedorf, Switzerland). For the LDH assay, following treatment, the culture medium of each well was collected for LDH determination. The optical absorbance at 450 nm was measured using a microplate reader. Results were expressed as the percentage of the absorbance of the control cells, which was considered as 100%.
Analysis of morphological changes. The PC12 cells were cultured and treated in a similar manner as described above. Following treatment, morphological changes were observed under a phase-contrast microscope (TS-100F; Nikon, Tokyo, Japan) and images of the cells were acquired using a digital camera(Olympus, Tokyo, Japan).
Cell apoptosis. Cell apoptosis was determined using two different methods, as follows:
i) Fluorescence staining. Following treatment as described above, the PC12 cells were stained with Hoechst 33342 (5 µg/ ml) after removing the culture medium, and the PC12 cells were then observed under a fluorescence microscope (Advanced Microscopy Group, Bothell, WA, USA) at x200 magnification in order to observe the apoptotic cells.
ii) Flow cytometric analysis. Following treatment, the PC12 cells were collected and quantified according to the manufacturer's instructions. Briefly, the PC12 cells were resuspended in binding buffer and stained with Annexin V/ PI for 15 min. The samples were then analyzed using a flow cytometer with an excitation wavelength of 488 nm and an emission wavelength of 530 nm (Becton-Dickinson, Bedford, MA, USA). Apoptotic cells were expressed as a percentage of the total number of cells.
Cellular permeability analysis by high-performance liquid chromatography (HPLC).
In this study, we found that PF at 100 µM exerted a significant neuroprotective effect; thus, we selected this concentration to explore its cell permeability. Briefly, the cells were treated with 100 µM PF for 4, 8 and 24 h to examine the cellular permeability of PF. Following treatment, the cells were washed with Tris-buffered saline and collected in a microcentrifuge tube with ice-cold lysis phosphate-buffered saline (PBS) buffer. The collections were vortexed after being sonicated. Intracellular PF was extracted by centrifugation at 12,000 x g for 15 min at 4̊C. The supernatant was then collected and filtered through a 0.22 µm PTFE membrane (Millipore, Milford, MA, USA) prior to injecting into the HPLC autosampler (Shimadzu Co., Kyoto, Japan). The samples were injected into the HPLC system (Shimadzu Co.) equipped with an diamonsil C18 reversed-phase column (I.D., 4.6 mm x 250 mm, 5 µm) at a flow rate of 1.0 ml/min using 30% water (containing 0.1% methanoic acid) and 70% acetonitrile as the mobile phase with a detection wavelength of UV 230 nm.
Western blot analysis. Following treatment, the cells were harvested and lysed using RIPA lysis buffer containing protease inhibitor cocktail (PMSF) on ice, and were subsequently centrifuged at 12,000 x g for 15 min at 4̊C. The supernatant was collected and the protein concentration was determined by the BCA method. The protein expression levels was then analyzed as described in a previous study (29) . Briefly, protein was electrophoresed on 12% density SDS acrylamide gels, transferred from the gel to PVDF membranes using an electric transfer system, and incubated with antibodies to caspase-3 (1:500), caspase-9 (1:500), p-Bad (1:500), Bcl-xL (1:1,000), Bax (1:1,000), Bcl-2 (1:1,000), cleaved PARP (1:1,000) and β-actin (1:1,000) overnight at 4̊C. Subsequently, the membranes were incubated for 2 h at room temperature with a secondary antibody (1:7,000). Finally, they were evaluated using the ECL western detection reagents on Image Lab analysis software (Bio-Rad Laboratories, Inc., Hercules, CA, USA). β-actin was used as a loading control. Three repeats of the experiments were performed.
Real-time PCR analysis. Following treatment, the cells were harvested and total RNA was extracted using TRizol reagent (Invitrogen, Barcelona, Spain). mRNA was reverse transcribed into cDNA according to the manufacturer's instructions of the PrimeScript ® RT reagent kit (Takara Bio, Inc., Otsu, Japan). cDNA was used as template for the Real-Time PCR assays with Power SYBR ® -Green PCR Master mix (Thermo Fisher Scientific, Inc., Shanghai, China). The PCR analysis was performed in a 7900 Real-Time PCR system (Applied Biosystems, Inc., Foster City, CA, USA) and the results were analyzed with software provided by the 7900 Real-Time PCR system. The results were expressed as the ratio between glutamate and control cells. Primer sequences used in the reactions were as follows: Bax reverse primer, 5'-GAT CAG CTC GGG CAC TTT AG-3' and forward primer, 5'-TGC AGA GGA TGA TTG CTG AC-3'; Bcl-2 reverse primer, 5'-ATG CCG GGT CAG GTA CTC AG-3' and forward primer, 5'-GGT GGT GGA GGA ACT CTT CA-3' .
Statistical analysis. Data are presented as the means ± standard deviation (SD). One-way analysis of variance (ANOVA) [SPSS 20.0 statistical software (SPSS, Inc., Chicago, IL, USA)] followed by a post hoc LSD test were used to evaluate multiple group differences. A value of P<0.05 was considered to indicate a statistically significant difference.
Results
Effect of PF on PC12 cell viability. The effect of PF itself on the basal growth of PC12 cells was examined. The results ( Fig. 2A) revealed that compared with the control group, the viability of the PC12 cells treated with PF alone at various concentrations was not significantly increased or decreased (in cells treated wth PF at 100, 200 and 300 µm, viability was 102.11±6.2, 100.11±6.5 and 99.81±6.6% of control, respectively).
Cytotoxic effects of glutamate on PC12 cells. The concentration-depe ndent response of glutamate-induced cytotoxicity was determined by MTT assay. The results revealed that cell viability was inhibited by glutamate with an IC 50 value of 17.181 mM (Fig. 2B) ; thus, glutamate at the concentration of 15 mM was selected for use in the subsequent experiments.
Effect of PF on the glutamate-induced decrease in PC12 cell viability. As shown in Fig. 2C , cell viability decreased to 51.5% of control following exposure to (15 mM) for 24 h. However, cell viability markedly increased to 59.4, 67.4 and 75.4% of the control following treatment with various concentrations of PF (100, 200 and 300 µM) prior to exposure to. glutamate Effect of PF on LDH release. The effect of PF on the release of LDH in the glutamate-exposed PC12 cells is shown in Fig. 2D . Exposure to glutamate (15 mM) for 24 h resulted in an increase in LDH release into the medium, which was significantly increased (261.92%) as compared with the control group. However, pre-treatment with various concentrations of PF (100, 200 and 300 µM) for 24 h decreased LDH leakage to 213.58, 150.51 and 122.02%, respectively.
Effect of PF on the apoptosis of PC12 cells. As shown in Fig. 3A , compared with the control group, the morphology of the PC12 cells in the glutamate group was markedly altered; the cells shrank and became round. However, cell morphology was protected when the cells were pre-treated with various concentrations of PF prior to exposure to glutamate.
Fluorescence staining was employed to investigate the nuclear of apoptosis cell. As shown in the Fig. 3B , apoptotic cells became thinner with pyknotic nuclei and exhibited light blue fluorescence following exposure to glutamate for 24 h; in addition, more nuclear fragmentation was observed than in the control cells. However, pre-treatment with various concentrations of PF (100, 200 and 300 µM) attenuated these changes and reduced the number of apoptotic cells.
To quantitatively demonstrate the effect of PF on glutamate-induced apoptosis, Annexin V/PI staining was evaluated by flow cytometric analysis. As shown in Fig. 4, 3 .54% of the total cells were apoptotic in the control group. However, the apoptotic rate was markedly increased to 9.86% vs. the control group following incubation with glutamate. Treatment with PF (100, 200 and 300 µM) markedly reduced the apoptotic ratio of the cells (cell apoptotic rate was 8.48, 6.03 and 5.9%, respectively).
Effects of PF on the expression of apoptosis-related proteins in PC12 cells.
The Bcl-2, Bax, Bcl-xL and p-Bad proteins belong to the Bcl-2 family and play an important role in cell apoptosis. Thus, we examined the expression of these proteins. The results (Fig. 5 ) revealed that compared with the control group, the protein expression levels of Bax and p-Bad were significantly increased following exposure to 15 mM glutamate for 24 h, whereas the levels of Bcl-2 and Bcl-xL were significantly decreased. However, after the cells were incubated with various concentrations of PF (100, 200 and 300 µM) for 24 h prior to expose to glutamate, the protein expression levels of Bax and p-Bad were decreased to 1.7-and 0.9-fold, 1.3-and 1.2-fold, and 1.1-and 1.1-fold of the glutamate group value, respectively, and the levels of Bcl-2 and Bcl-xL increased to 1.2-and 0.4-fold, 1.0-and 0.9-fold, 1.1-and 0.9-fold of the glutamate group value.
The Bcl-2 family exerts its pro-or anti-apoptotic effects and activates caspase-9 and caspase-3, leading to apoptosis. Thus, we also examined the levels of caspase-9 and caspase-3. As shown in Fig. 6 , glutamate elevated the activity of caspase-3 and caspase-9 in the PC12 cells, while the levels of caspase-3 and caspase-9 were significantly decreased by PF. Moreover, PARP is a family of proteins involved in a number of cellular processes involving mainly DNA repair and programmed cell death. It can be activated in cells experiencing stress and/or DNA damage and is inactivated by caspase cleavage. We also thus exmained the expression of PARP. As shown in Fig. 6 , exposure to glutamate for 24 h significantly increased the protein level of cleaved PARP, whereas this was markedly reversed by PF pre-treatment.
Effects of PF on the mRNA expression of Bcl-2 and Bax. As presented in Fig. 7 , the real-time PCR analysis revealed that exposure to glutamate increased the mRNA level of Bax and decreased the mRNA level of Bcl-2. By contrast, PF treatment profoundly downregulated the mRNA level of Bax and upregulated the mRNA level of Bcl-2.
Effect of PF on cell permeability. The permeability of PF across the membrane barrier in PC12 cells was evaluated by HPLC with the index of the intracellular content of PF. As shown in Fig. 8 , treatment with 100 µM PF for 8, 12 and 24 h resulted in an increase of PF incorporation to 0.54, 13.4 and 24 µM, respectively.
Discussion
Ischemic stroke is third leading cause of mortality worldwide and is associated with a high incidence of long-term disability in surviving individuals (30) . It triggers a complex cascade of pathophysiological processes, including excitotoxicity, oxidative stress, calcium overload, inflammation and apoptosis (31, 32) . Excitotoxicity is a major event that induces neuronal death in ischemic stroke (33) . Glutamate is an excitatory neurotransmitter, which exists in abundance in the hippocampus, the brain cortex and other body parts of the central nervous system. Under pathological conditions, the content of glutamate is increased, and causes the influx of Ca 2+ , leading to the apoptosis and necrosis of neurons through various mechanisms. As such, glutamate is widely used as an excitotoxicity-inducing agent to study the molecular mechanisms and to develop drugs for ischemic stroke therapy (34) (35) (36) .
The exogenous addition of glutamate into cultured cells induces cells to undergo a series of processes, such as cell excitotoxicity, DNA fragmentation and cell apoptosis. PC12 cells are derived from Rattus norvegicus pheochromocytoma tumors, and it has been proven that their cell morphology and physiological function are very similr to those of neurons, and the NMDA receptor with strong affinity for glutamate, is expressed in abundance in PC12 cell membranes (37, 38) . Therefore, the PC12 cell line has been used as an in vitro experimental model of cerebral ischemia. Previous studies in PC12 cells have found that glutamate exposure significantly induces apparent cell morphological changes, a decrease in cell viability and apoptosis (39, 40) . In this study, the exposure of the PC12 cells to glutamate significantly altered the cell morphological characteristics and decreased cell viability; similar results were obtained from Hoechst 33342 staining and Annexin V/PI staining. Glutatamate also increased the LDH release from PC12 cells. These findings were consistent with those of previous studies (39, 40) . Of note, pre-treatment of the PC12 cells with PF markedly increased cell viability and decreased the LDH release, which implied that PF protected the PC12 cells agaist glutamate-induced cytotoxicity, at least partially, due to its anti-apoptotic effects.
To the best of our knowledge, the apoptosis of neurons plays an important role in the cerebral ischemia inducedcascade response (41, 42) . A number of genes and proteins can influence the progression of apoptosis along the mitochondrial pathway (10) . The most important genes of apoptosis are proteins of the Bcl family and caspases (11, 12) . There are two groups, anti-apoptotic (Bcl-2, Bcl-xL) and pro-apoptotic (Bax, Bad) proteins in the Bcl-2 family (42). The abnormal expression levels of pro-apoptotic proteins and anti-apoptotic proteins are considered to determine cell death or survival by controlling apoptosis (43, 44) . Previous studies have indicated that the Bcl-2 family plays a vital regulatory role in cell apoptosis (15, 45) . The Bcl-2 and Bcl-xL proteins are the major anti-apoptotic factors. In the present study, treatment with PF prior to exposure to glutamate for 24 h significantly increased the Bcl-2 and Bcl-xL expression level and decreased the Bax and Bad expression level. Moreover, Bcl-2 mRNA expression was increased and Bax mRNA expression was decreased. This result implied that Apoptogenic factors release and activate the executioners of apoptosis, the caspases (46) . It has been found that caspases play an important role in the apoptotic process; the regulation of caspases has a shown promising effect in attenuating apoptosis (47) . Caspase-3 is the executive factor of apoptosis, as it activates DNA fragmentation, which in turn activates endonucleases to cleave nuclear DNA and as a result, leads to cell death (48, 49) . Caspase-9 is an initiator caspase and is activated during programmed cell death (apoptosis). Once initiated, caspase-9 then cleaves pro-caspase-3, which cleaves several cellular targets. In the present study, glutamate markedly increased caspase-3 and caspase-9 protein expression. However, pre-incu bation with PF decreased their expression. Combined with results of cell viability, the results of Annexin V/PI staining and the analysis of the upstream and downstream mitochondrial apoptosis-associated proteins (Bcl-2, Bcl-xL, Bax, Bad, caspase-3 and -9), indicated that PF inhibited the apoptosis of PC12 cells induced by glutamate, which was consistent with the study of Sun et al (50) . Their study proved that PF was able to protect PC12 cells from glutamate-induced cytotoxicity and apoptosis by investigating cell apoptosis, as well as mitochondrial membrane potential (MMP) by flow cytometric analysis and the expression profiles of Bcl-2 and Bax by western blot analysis. In this study, we demonstrated these effects by analyzing the protein expression profiles of Bcl-2, Bcl-xL, Bax, Bad, cleaved PARP, caspase-3 and caspase-9, as well as the mRNA expression of Bcl-2 and Bax. It is known that PF is a water-soluble compound, and not liposoluble compounds or materials are not easy to penetrate cell membranes (51) . Thus, we investigated whether it can pass through the cytomembrane when PC12 cells were incubated with PF in vitro. The intracellular concentrations of PF in PC12 cells were determined by HPLC analysis. The results illustrated that PF had difficulty passing through cytomembrane, even after 24 h of incubation as only small amounts had passed through. This suggested that the protective effect of PF on glutamate-induced PC12 cell cytotoxicity was mainly provided with a small quantity of PF incorporating into the PC12 cells. Therefore, it was legitimately concluded that the elevation in the penetrability of PF could obviously produce a stronger protective effect than our present results in glutamate-exposed PC12 cells. Although PF has been proven to exert potent neuroprotective effects, and in this study we used PF to testify the intercellular peak, and we found that PF was detected in cells, we presumed that PF may be the active substance. PF may be metabolized in PC12 cells and perhaps its metabolite is also the active substance. This requires further investigation in future studies.
In conclusion, the results of this study indicated that PF is able to protect PC12 cells from glutamate-induced cytotoxicity and apoptosis by upregulating Bcl-2, Bcl-xL, downregulating Bax, Bad, cleaved PARP and ultimately inhibiting caspase-3 and caspase-9 activity. Therefore, PF may be a potential neuroprotective compound which may be used to protect against neuronal injury induced by glutamate. However, further studies are required in order to further elucidate the underlying molecular mechanisms.
